SARS-CoV-2 in the Preimplantation Embryo Covid-19 a new initiative working in

a new initiative working in collaboration with the world’s zoos for the long-term storage of live cells from animal species that are at the greatest risk of extinction

He retired from clinical embryology in 2003 and pursued a career in setting up and running startup companies sub-specializing in diagnostic and therapeutic aspects in assisted reproductive technology

outside clinician consulting and is an expert in US Food and Drug Administration (FDA)

Athensand Nordica Fertility Centre in Lagos and product developer in a wide range of areaswithin the industry

SARS-CoV-2 in the Preimplantation Embryo Covid-19 a new initiative working inSARS CoV 2 in the Preimplantation Embryotion Tuesday 6th April, 2021. DR. MANUEL VIOTTI Dr. Manuel Viotti is Senior Scientist at the Zouves Foundation for Reproductive Medicine. He heads the research efforts to improve outcomes in the IVF clinic, with a special focus on molecular and cell biology of the embryo and uterine environment. He earned his PhD in developmental biology from Weill Cornell Graduate School of Medical Sciences and the Sloan